Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 5:6:20736.
doi: 10.1038/srep20736.

Association between Serum IGF-I levels and Postoperative Delirium in Elderly Subjects Undergoing Elective Knee Arthroplasty

Affiliations

Association between Serum IGF-I levels and Postoperative Delirium in Elderly Subjects Undergoing Elective Knee Arthroplasty

Timothy E Yen et al. Sci Rep. .

Abstract

Evidence is mixed for an association between serum insulin-like growth factor-I (IGF-I) levels and postoperative delirium (POD). The current study assessed preoperative serum IGF-I levels as a predictor of incident delirium in non-demented elderly elective knee arthroplasty patients. Preoperative serum levels of total IGF-I were measured using a commercially available Human IGF-I ELISA kit. POD incidence and severity were determined using DSM-IV criteria and the Delirium Rating Scale-Revised-98 (DRS-R98), respectively. Median IGF-I levels in delirious (62.6 ng/ml) and non-delirious groups (65.9 ng/ml) were not significantly different (p = 0.141). The ratio (95% CI) of geometric means, D/ND, was 0.86 (0.70, 1.06). The Hodges-Lehmann median difference estimate was 7.23 ng/mL with 95% confidence interval (-2.32, 19.9). In multivariate logistic regression analysis IGF-I level was not a significant predictor of incident POD after correcting for medical comorbidities. IGF-I levels did not correlate with DRS-R98 scores for delirium severity. In conclusion, we report no evidence of association between serum IGF-I levels and incidence of POD, although the sample size was inadequate for a conclusive study. Further efforts to investigate IGF-I as a delirium risk factor in elderly should address comorbidities and confounders that influence IGF-I levels.

PubMed Disclaimer

Conflict of interest statement

Dr. Trzepacz was a full-time salaried employee and minor shareholder of Eli Lilly and Company during the conduct of this study, and copyright owner of the Delirium Rating Scale-Revised-98 but does not charge a fee for not-for-profit use of this scale.

Figures

Figure 1
Figure 1. Distributions of preoperative IGF-I serum levels by percentage for delirious and non-delirious groups.
The distributions of IGF-I concentrations for the Delirious and Non-delirious groups exhibited considerable overlap, and there was no difference in median IGF-I levels between groups.

Similar articles

Cited by

References

    1. Rudolph J. L. & Marcantonio E. R. Review articles: postoperative delirium: acute change with long-term implications. Anesth. Analg. 112, 1202–1211 (2011). - PMC - PubMed
    1. Thomas R. I., Cameron D. J. & Fahs M. C. A prospective study of delirium and prolonged hospital stay. Exploratory study. Arch. Gen. Psychiatry 45, 937–940 (1988). - PubMed
    1. Franco K., Litaker D., Locala J. & Bronson D. The cost of delirium in the surgical patient. Psychosomatics 42, 68–73 (2001). - PubMed
    1. Leslie D. L. & Inouye S. K. The importance of delirium: economic and societal costs. J. Am. Geriatr. Soc. 59 Suppl 2, S241–243 (2011). - PMC - PubMed
    1. Fong T. G. et al. Delirium accelerates cognitive decline in Alzheimer disease. Neurology 72, 1570–1575 (2009). - PMC - PubMed

Substances